Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kholoud Alqasem"'
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 11, Iss , Pp 100243- (2023)
Introduction: The phase-3 MONALEESA-2, -3 and -7 randomized trials showed benefit of CDK4/6 inhibitor, ribociclib, in women with advanced-stage breast cancer. However, ribociclib-induced acute kidney injury (AKI) was not addressed in these studies. I
Externí odkaz:
https://doaj.org/article/bca9d08d3b5a4b49af68c4e02a342948
Autor:
Ali Shamseddine, Youssef H. Zeidan, Ziad El Husseini, Malek Kreidieh, Monita Al Darazi, Rim Turfa, Joseph Kattan, Ibrahim Khalifeh, Deborah Mukherji, Sally Temraz, Kholoud Alqasem, Rula Amarin, Tala Al Awabdeh, Samer Deeba, Faek Jamali, Issa Mohamad, Mousa Elkhaldi, Faiez Daoud, Mahmoud Al Masri, Ali Dabous, Ahmad Hushki, Omar Jaber, Maya Charafeddine, Fady Geara
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-7 (2020)
Abstract Background Neoadjuvant chemotherapy and short-course radiotherapy followed by resection has been gaining recognition in the treatment of rectal cancer. Avelumab is a fully human immunoglobulin that binds Programmed Death-Ligand 1 (PD-L1) and
Externí odkaz:
https://doaj.org/article/2180191c328b48ef81ea5437c44cae05
Autor:
Ali Shamseddine, Youssef H. Zeidan, Malek Kreidieh, Ibrahim Khalifeh, Rim Turfa, Joseph Kattan, Deborah Mukherji, Sally Temraz, Kholoud Alqasem, Rula Amarin, Tala Al Awabdeh, Samer Deeba, Faek Jamali, Issa Mohamad, Mousa Elkhaldi, Faiez Daoud, Mahmoud Al Masri, Ali Dabous, Ahmad Hushki, Omar Jaber, Clement Khoury, Ziad El Husseini, Maya Charafeddine, Monita Al Darazi, Fady Geara
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Current standard practice for locally advanced rectal cancer (LARC) entails a multidisciplinary approach that includes preoperative chemoradiotherapy, followed by total mesorectal excision, and then adjuvant chemotherapy. The latt
Externí odkaz:
https://doaj.org/article/65797dc607cf443788a4ecaaacc48962
Autor:
Hanin Shaqboua, Dina Braik, Baha' Sharaf, Abdallah Al-Tell, Rawan Mustafa, Hikmat Abdel-Razeq, Saba Jaradat, Rayan Bater, Razan Mansour, Khaled Ashouri, Jamil Qarqash, Kholoud Alqasem, Zaid Omari
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Scientific Reports
Scientific Reports
Patients with gastric cancer are at higher risk for venous thromboembolic events (VTE). Majority of such patients are treated in ambulatory settings where thromboprophylaxis is not routinely offered. In this study, we report on VTE rates and search f
Autor:
Ahmad Hushki, Maya Charafeddine, Clement El Khoury, Faiez Daoud, Ali Dabous, Faek R. Jamali, Mahmoud Al Masri, Ibrahim Khalifeh, Rula Amarin, Malek Kreidieh, Ali Shamseddine, Issa Mohamad, Mousa Elkhaldi, Monita Al Darazi, Rim Turfa, Kholoud Alqasem, Samer Deeba, Omar Jaber, Deborah Mukherji, Fady Geara, Joseph Kattan, Ziad El Husseini, Tala Al Awabdeh, Youssef H. Zeidan, Sally Temraz
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer
BMC Cancer
Background Current standard practice for locally advanced rectal cancer (LARC) entails a multidisciplinary approach that includes preoperative chemoradiotherapy, followed by total mesorectal excision, and then adjuvant chemotherapy. The latter has be
Autor:
Maissoune Hajir, Ramiz Ahmad Abu-Hijlih, Areej Abu Sheikha, Kholoud Alqasem, Hikmat Abdel-Razeq
Publikováno v:
Journal of Clinical Oncology. 40:1063-1063
1063 Background: The phase-3 MONALEESA-2,-3 and -7 randomized trials showed improved progression-free survival (PFS) and overall survival (OS) with the addition of cyclin D-cyclin-dependent kinase 4/6 (CDK4/6) inhibitor ribociclib to endocrine therap
Autor:
Ali Shamseddine, Ibrahim Moustafa Khalifeh, Charbel Elias, Rim Turfa, Joseph Gergi Kattan, Deborah Mukherji, Sally Naji Temraz, Kholoud Alqasem, Rula Amarin, Tala Alawabdeh, Samer Deeba, Issa Mohamad, Faiez Daoud, Mahmoud Al Masri, Ali Dabous, Ahmad Hushki, Omar Jaber, Maya Charafeddine, Lama Farhat, Ayman Tawil
Publikováno v:
Journal of Clinical Oncology. 40:184-184
184 Background: The immunoscore (IS), a prognostic score, was first validated in early colon cancer reflecting the immune response against the tumor. It showed potential in its ability to downstage patients with pathologic complete response (pCR) who
Autor:
Ibrahim Khalifeh, Ali Dabous, Faiez Daoud, Rula Amarin, Samer Deeba, Deborah Mukherji, Joseph Kattan, Faek R. Jamali, Fady Geara, Mousa Elkhaldi, Maya Charafeddine, Issa Mohamad, Ziad El Husseini, Kholoud Alqasem, Ali Shamseddine, Ahmad Hushki, Monita Al Darazi, Tala Al Awabdeh, Youssef H. Zeidan, Omar Jaber, Rim Turfa, Malek Kreidieh, Sally Temraz, Mahmoud Al Masri
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-7 (2020)
Radiation Oncology, Vol 15, Iss 1, Pp 1-7 (2020)
BackgroundNeoadjuvant chemotherapy and short-course radiotherapy followed by resection has been gaining recognition in the treatment of rectal cancer. Avelumab is a fully human immunoglobulin that binds Programmed Death-Ligand 1 (PD-L1) and prevents
Autor:
Shamseddine, Ali, Zeidan, Youssef H., Husseini, Ziad El, Kreidieh, Malek, Monita Al Darazi, Turfa, Rim, Kattan, Joseph, Khalifeh, Ibrahim, Mukherji, Deborah, Temraz, Sally, Kholoud Alqasem, Amarin, Rula, Awabdeh, Tala Al, Deeba, Samer, Faek Jamali, Mohamad, Issa, Elkhaldi, Mousa, Faiez Daoud, Masri, Mahmoud Al, Dabous, Ali, Hushki, Ahmad, Jaber, Omar, Charafeddine, Maya, Geara, Fady
Additional file1: Protocol. Protocol of Averectal study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350b815095f02e32f848d5ad2e16c9d0
Autor:
Faiez Daoud, Ali Dabous, Rula Amarin, Rim Turfa, Samer Deeba, M. Al Darazi, Ali Shamseddine, Issa Mohamad, T. Al Awabdeh, Maya Charafeddine, Kholoud Alqasem, Mousa Elkhaldi, Joseph Kattan, Ahmad Hushki, Youssef Bouferraa, Sally Temraz, Youssef H. Zeidan, Deborah Mukherji, S. Doughan, M. Al Masri, F. Geara
Publikováno v:
Annals of Oncology. 32:S215